| DC Field | Value | Language |
|---|
| dc.contributor.author | Peresypkina, A. | - |
| dc.contributor.author | Pazhinsky, A. | - |
| dc.contributor.author | Pokrovskii, M. | - |
| dc.contributor.author | Beskhmelnitsyna, E. | - |
| dc.contributor.author | Pobeda, A. | - |
| dc.contributor.author | Korokin, M. | - |
| dc.date.accessioned | 2020-02-21T09:18:45Z | - |
| dc.date.available | 2020-02-21T09:18:45Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | Correction of Experimental Retinal Ischemia by L-Isomer of Ethylmethylhydroxypyridine Malate / A. Peresypkina [et al.] // Antioxidants. - 2019. - Vol.8, №2.-Art. 34. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/28686 | - |
| dc.description.abstract | An important task of pharmacology and ophtalmology is to find specific and highly effective agents for correcting retinal ischemia. The objective of this study is to increase the effectiveness of pharmacological correction of retinal ischemia by using new 3-hydroxypyridine derivative-L-isomer of ethylmethylhydroxypyridine malate | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | ophthalmology | ru |
| dc.subject | pharmacology | ru |
| dc.subject | retinal ischemia | ru |
| dc.subject | L-isomer of ethylmethylhydroxypyridine malate | ru |
| dc.subject | Emoxipine | ru |
| dc.subject | b/a coefficient | ru |
| dc.subject | experimental pharmacology | ru |
| dc.title | Correction of Experimental Retinal Ischemia by L-Isomer of Ethylmethylhydroxypyridine Malate | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
